友華生技醫藥股份有限公司 Approved
最後更新時間 2025/07/11 , 03:46 AM
最後更新時間 2025/07/11 , 03:46 AM
負責人
Cai,Zheng-Hong
統一編號
12397982
成立日期
1982/06/16
資本額
NT$1,000,000,000
實收資本額
NT$867,471,190
股票代號
4120
電話
02-27554881
地址
13F, No. 128, Sec. 6, Chengde Rd., Beitou Dist., Taipei City, 112, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Cai,Zheng-Hong Chairman 11.72% TAIWAN EXCELSIOR CO., LTD.
Lin,Shu-Fen Director 11.72% TAIWAN EXCELSIOR CO., LTD.
Cai,Meng-Lin Director 1.15%
Lin,Hua-Ming Independent Director 0.00%
Praveen Tyle Independent Director 0.00%
Xu,Jing-Xin Independent Director 0.00%
Lin,Shui-Yong Independent Director 0.00%
營業項目
  • Manufacture of Drugs and Medicines(200211)
  • Retail Sale of Pharmaceutical and Medical Goods in Specialized Stores(475112)
  • Retail Sale of Pharmaceutical and Medical Goods in Specialized Stores(475113)
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程
    員工人數
    財務報表
    項目 2025 2024 2023
    Operating income 1,156,213 4,391,301 4,591,894
    Operating cost 599,115 2,325,131 2,444,674
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 557,098 2,066,170 2,147,220
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 557,098 2,066,170 2,147,220
    Operating expenses 628,935 2,072,885 2,076,608
    Other gain (loss), net - - -
    Operating profit (loss) -71,837 -6,715 70,612
    Non-operating income and expenses -29,524 -123,275 185,642
    Net profit (loss) before tax -101,361 -129,990 256,254
    Income tax expense (benefits) 31,076 101,207 86,967
    Net profit (loss) of ongoing business for the current period -132,437 -231,197 169,287
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -132,437 -231,197 169,287
    Other comprehensive profit (loss), net 543,069 2,094,126 564,995
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 410,632 1,862,929 734,282
    Net profit (loss) attributable to owners of parent company -153,724 -283,934 143,943
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests 21,287 52,737 25,344
    Comprehensive profit (loss) attributable to owners of parent company 388,167 1,806,820 709,149
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 22,465 56,109 25,133
    Basic earnings per share (yuan) -1 -3 1
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -12,275 -121,108 120,980
    Net cash inflows (outflows) from investing activities -87,652 465,200 62,107
    Net cash inflow (outflow) from financing activities -59,229 -760,917 -209,709
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 69,395 115,797 -38,283
    Increase (decrease) in cash and cash equivalents in the current period -89,761 -301,028 -64,905
    Beginning balance of cash and cash equivalents 1,435,088 1,736,116 1,801,021
    Ending balance of cash and cash equivalents 1,345,327 1,435,088 1,736,116
    項目 2025 2024 2023
    Current asset 3,644,408 3,975,672 4,227,641
    Non-current asset 8,177,610 7,594,613 6,584,153
    Total asset 11,822,018 11,570,285 10,811,794
    Current liability 3,281,949 3,307,964 3,712,225
    Non-current liability 2,350,294 2,437,896 2,937,089
    Total liability 5,632,243 5,745,860 6,649,314
    share capital 867,471 867,471 867,471
    Equity - secruity token - - -
    capital reserve 271,263 271,263 271,263
    retained earning 2,170,558 2,046,328 1,751,629
    Other equity 2,197,630 1,978,975 624,122
    Treasury stock - - -
    Total equity attributable to owners of parent company 5,506,922 5,164,037 3,514,485
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 682,853 660,388 647,995
    Total Equity 6,189,775 5,824,425 4,162,480
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 63 59 40
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 友華宜祛痘
  • OEPISOTRETOR
  • ISOTRETOR
  • Nutrikept
  • BabePaws
  • 貝比寵兒
  • Vitadeer
  • 卡洛鹿益
  • 金愛鹿益
  • Karideer
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Others
    2007, 2008
  • Return deposit
    2009
  • Pay severance pay
    2011
  • Compensation for damage
    2007, 2009
  • Pay severance pay, etc.
    2014
  • Infringement damage compensation
    2015
  • Others
    2003, 2008, 2024
  • Payment order
    2011, 2013, 2014, 2015, 2016
  • Pay the ticket
    2003, 2008, 2011
  • Return deposit
    2011
  • Pay for the goods
    2007, 2008, 2013
  • Pay severance pay
    2012, 2013
  • Trademark Evaluation
    2015
  • Trademark opposition
    2007, 2008
  • Business encroachment
    2008
  • Invalidating Judgment
    2004
  • Promissory note ruling
    2007, 2012, 2013, 2016
  • Compensation for damage
    2009, 2012
  • Invalidating Judgment (Note)
    2012, 2022, 2024
  • Compensation for damage, etc.
    2016
  • Request for damage compensation
    2011
  • Request for severance pay, etc.
    2014
  • Petition filed for public summons
    2004, 2011, 2022, 2023
  • Request for damage compensation, etc.
    2018
  • Infringement of patent rights related to property rights disputes, etc.
    2010, 2011
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。